Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(17%)
Results Posted
29%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph early_phase_1
1
6%
Ph phase_3
5
28%
Ph not_applicable
3
17%
Ph phase_4
2
11%
Ph phase_1
2
11%
Ph phase_2
5
28%

Phase Distribution

3

Early Stage

5

Mid Stage

7

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
2(11.1%)
Phase 2Efficacy & side effects
5(27.8%)
Phase 3Large-scale testing
5(27.8%)
Phase 4Post-market surveillance
2(11.1%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

18

all time

Status Distribution
Active(5)
Completed(7)
Terminated(1)
Other(5)

Detailed Status

Completed7
unknown5
Recruiting3
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
3
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.6%)
Phase 12 (11.1%)
Phase 25 (27.8%)
Phase 35 (27.8%)
Phase 42 (11.1%)
N/A3 (16.7%)

Trials by Status

recruiting317%
not_yet_recruiting211%
unknown528%
completed739%
terminated16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04207931Phase 4

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Recruiting
NCT05417308Early Phase 1

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Recruiting
NCT07273799Phase 3

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Not Yet Recruiting
NCT07264790Phase 1

Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Not Yet Recruiting
NCT00876200Phase 2

Efficacy of Minoxidil in Children With Williams-Beuren Syndrome

Completed
NCT06924632Phase 3

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

Recruiting
NCT05272462Phase 2

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Unknown
NCT05990400Phase 2

Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Unknown
NCT05864885Phase 1

Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

Unknown
NCT01309191Not Applicable

Microarray Analysis of Scalp Biopsies After Minoxidil Treatment

Completed
NCT04293822Phase 4

Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia

Unknown
NCT03528772Not Applicable

Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure

Completed
NCT00175617Phase 2

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Completed
NCT00151515Phase 3

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

Completed
NCT00607477Not Applicable

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

Terminated
NCT01319370Phase 2

Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia

Completed
NCT01655108Phase 3

Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

Unknown
NCT00958750Phase 3

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18